| Authors: |
Breen DM; Internal Medicine Research Unit, Pfizer Inc., 1 Portland Street, Cambridge, MA, USA. Electronic address: danna.breen@pfizer.com., Kim H; Internal Medicine Research Unit, Pfizer Inc., 1 Portland Street, Cambridge, MA, USA., Bennett D; Biostatistics, Early Clinical Development, Pfizer Inc., 1 Portland Street, Cambridge, MA, USA., Calle RA; Internal Medicine Research Unit, Pfizer Inc., 1 Portland Street, Cambridge, MA, USA., Collins S; Biostatistics, Early Clinical Development, Pfizer R&D UK Limited, Ramsgate Road, Sandwich, Kent, UK., Esquejo RM; Internal Medicine Research Unit, Pfizer Inc., 1 Portland Street, Cambridge, MA, USA., He T; Biomedicine Design, Pfizer Inc., 1 Portland Street, Cambridge, MA, USA., Joaquim S; Internal Medicine Research Unit, Pfizer Inc., 1 Portland Street, Cambridge, MA, USA., Joyce A; Biomedicine Design, Pfizer Inc., 1 Burtt Road, Andover, MA, USA., Lambert M; Biomedicine Design, Pfizer Inc., 1 Portland Street, Cambridge, MA, USA., Lin L; Biomedicine Design, Pfizer Inc., 1 Portland Street, Cambridge, MA, USA., Pettersen B; Drug Safety Research and Development, Pfizer Inc., 1 Portland Street, Cambridge, MA, USA., Qiao S; Internal Medicine Research Unit, Pfizer Inc., 1 Portland Street, Cambridge, MA, USA., Rossulek M; Internal Medicine Research Unit, Pfizer Inc., 1 Portland Street, Cambridge, MA, USA., Weber G; Biomedicine Design, Pfizer Inc., 1 Portland Street, Cambridge, MA, USA., Wu Z; Internal Medicine Research Unit, Pfizer Inc., 1 Portland Street, Cambridge, MA, USA., Zhang BB; Internal Medicine Research Unit, Pfizer Inc., 1 Portland Street, Cambridge, MA, USA., Birnbaum MJ; Internal Medicine Research Unit, Pfizer Inc., 1 Portland Street, Cambridge, MA, USA. |
